• Dongming Zhao

    Mr. Zhao Dongming joined MicuRx in early 2020 and is responsible for the marketing and commercialization of MicuRx’s new drugs in China. Prior to joining MicuRx, Mr. Zhao held various management positions at Eddingpharm, Gilead, Novartis, and Pfizer, and has over 25 years of experience in successfully leading multinational pharmaceutical companies to launch and commercialize new drugs in China. Before that, Mr. Zhao worked as an intensive care physician at Beijing Friendship Hospital.